XML 40 R32.htm IDEA: XBRL DOCUMENT v3.24.4
NET LOSS PER SHARE OF COMMON STOCK (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2024
Dec. 31, 2023
Earnings Per Share [Abstract]    
SCHEDULE OF COMPUTATION OF ANTI-DILUTIVE WEIGHTED-AVERAGE SHARES OUTSTANDING

Presented below are the calculations of the Numerators and the Denominators for basic and diluted EPS (dollars in thousands, except per share amounts): 

 

   2024   2023   2024   2023 
  

For the Three Months Ended

September 30,

  

For The Nine Months Ended

September 30,

 
   2024   2023   2024   2023 
Calculation of Numerator:                
Net loss  $(2,616)   (2,093)  $(8,309)   (9,324)
Loss applicable to common stockholders  $(2,616)  $(2,093)  $(8,309)  $(9,324)
Calculation of Denominator:                    
Weighted average number of shares of Common Stock outstanding   6,615,320    1,197,258    4,282,210    1,152,607 
Net loss per share of Common Stock (basic and diluted)  $(0.40)  $(1.75)  $(1.94)  $(8.09)

Presented below are the calculations of the Numerators and the Denominators for basic and diluted EPS (dollars in thousands, except per share amounts):

SCHEDULE OF COMPUTATION OF ANTI-DILUTIVE WEIGHTED-AVERAGE SHARES OUTSTANDING 

   2023  

 2022

 
Calculation of Numerator:          
Net loss  $(13,583)   (23,845)
           
Loss applicable to common stockholders  $(13,583)  $(23,845)
           
Calculation of Denominator:          
Weighted average number of shares of Common Stock outstanding   1,219,381    920,592 
           
Net loss per share of Common Stock (basic and diluted)  $(11.14)  $(25.90)
SCHEDULE OF OUTSTANDING COMMON STOCK SECURITIES NOT INCLUDED IN THE COMPUTATION OF DILUTED NET LOSS PER SHARE

As of September 30, 2024 and 2023, the following potential Common Stock equivalents were excluded from the computation of diluted net loss per share of Common Stock since the impact of inclusion was antidilutive (in thousands): 

 

   September 30, 2024   September 30, 2023 
Common stock warrants   9,244    496 
Common stock options   228    137 
Total   9,472    633 

As of December 31, 2023 and 2022, the following potential Common Stock equivalents were excluded from the computation of diluted net loss per share of Common Stock since the impact of inclusion was antidilutive (in thousands):

 SCHEDULE OF OUTSTANDING COMMON STOCK SECURITIES NOT INCLUDED IN THE COMPUTATION OF DILUTED NET LOSS PER SHARE

   2023   2022 
 
Common stock warrants   2,822    145 
Common stock options   127    145 
Total   2,949    290